Consent in Pharmacogenetic Testing

Affiliations

¹ Yuichi Ando, MD, PhD, Department Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan and Tomohiro Terada, PhD, Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital. Kyoto, Japan.

Comment

Yuichi Ando et al. J Clin Oncol. 2023.

. 2023 Aug 1;41(22):3875.

doi: 10.1200/JCO.23.00664. Epub 2023 Jun 2.

¹ Yuichi Ando, MD, PhD, Department Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan and Tomohiro Terada, PhD, Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital. Kyoto, Japan.

No abstract available

Comment on

DPYD Testing: Time to Put Patient Safety First.
Baker SD, Bates SE, Brooks GA, Dahut WL, Diasio RB, El-Deiry WS, Evans WE, Figg WD, Hertz DL, Hicks JK, Kamath S, Kasi PM, Knepper TC, McLeod HL, O'Donnell PH, Relling MV, Rudek MA, Sissung TM, Smith DM, Sparreboom A, Swain SM, Walko CM. Baker SD, et al. J Clin Oncol. 2023 May 20;41(15):2701-2705. doi: 10.1200/JCO.22.02364. Epub 2023 Feb 23. J Clin Oncol. 2023. PMID: 36821823 Free PMC article. No abstract available.